Last A$0.0030 AUD
Change Today 0.00 / 0.00%
Volume 0.0
MDV On Other Exchanges
Symbol
Exchange
Berlin
As of 2:16 AM 09/30/13 All times are local (Market data is delayed by at least 15 minutes).

medivac ltd (MDV) Snapshot

Open
--
Previous Close
A$0.0030
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
A$-0.0026
Shares Outstanding
834.2M
EX-Date
09/11/95
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIVAC LTD (MDV)

Related News

No related news articles were found.

medivac ltd (MDV) Related Businessweek News

No Related Businessweek News Found

medivac ltd (MDV) Details

Medivac Limited develops clinical technology products for application in hospital and other medical settings in Australia and internationally. The company’s portfolio of clinical technology products include SunnyWipes, which consists of various antimicrobial hand hygiene and general cleaning products; and Diakyne, a product that identifies trace elements in body fluids using the Tracesmart technology. It also acts as an investment manager; and operates a portfolio of investments in micro-cap companies, companies at pre initial public offering stage, and companies involved in the resources sector. Medivac Limited is based in Melbourne, Australia.

medivac ltd (MDV) Top Compensated Officers

Managing Director and Director
Total Annual Compensation: --
Finance Manager
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Company Secretary
Total Annual Compensation: --
Operations Manager – Medivac Technology
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

medivac ltd (MDV) Key Developments

Medivac Limited Announces Resignation of Peter Elliott as Director

The directors of Medivac Limited announced that Mr. Peter Elliott will resign as director of the company effectively immediately.

Medivac Limited Announces Board Changes

The Board of Medivac Limited advised that Mr. Robert Crossman has been appointed as a director and non-executive Chairman, effective immediately. Mr. Crossman has over 20 years' experience in merger and acquisition, equity capital markets, project finance and corporate advisory. Prior to founding Corpac, Mr. Crossman was Head of Investment Banking at Hartley Poynton, the Managing Director of ABN Amro Rothschild and Managing Director in Investment Banking at N.M. Rothschild & Sons. The Directors also advised that Mr. Kieran Honour has resigned as director of the company effectively immediately.

Medivac Limited Appoints Peter Elliott as Non-Executive Director

The Board of Medivac Limited announced the appointment of Mr. Peter Elliott as Non-Executive Director of the Company. Mr. Elliott holds a Bachelor of Laws degree from the University of Auckland and is an admitted Barrister & Solicitor, with more than 30 years of commercial experience including senior executive positions with corporate services and trustee services providers, and extensive involvement in both corporate structuring and corporate compliance work.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDV:AU A$0.00 AUD 0.00

MDV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDV.
View Industry Companies
 

Industry Analysis

MDV

Industry Average

Valuation MDV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIVAC LTD, please visit www.medivac.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.